PetIQ Sets Estimated IPO Pricing

Eagle, Idaho-based PetIQ, which manufactures prescription flea and tick prevention medications, as well as health and wellness products for dogs and cats, has set its estimated IPO pricing, saying in a filing that it expects to price its IPO at between $14.00 an $16.00 per share is looking to sell 5.67 million shares of its stock on the NASDAQ Global Market as PETQ. The company is backed by Eos Funds, Labore et Honore, Porchlight Entities, True Science Founders, and NBTS Holdings. McCord Christensen is CEO of the company.